Atlas Trials

Moderate-to-severe Chronic Plaque Psoriasis

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Moderate-to-severe Chronic Plaque Psoriasis

RecordFirmDate
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT05335356)Biocon Biologics UK Ltd2022-06-28
Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT04785326)Dong-A ST Co., Ltd.2021-04-28
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis (NCT03997786)Sun Pharmaceutical Industries Limited2020-01-15
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03598790)UCB Biopharma SRL2018-09-05
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03536884)UCB Biopharma SRL2018-06-13
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03410992)UCB Biopharma SRL2018-02-05
Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis (NCT03463187)Jiangsu HengRui Medicine Co., Ltd.2017-12-15
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT02223039)AbGenomics B.V Taiwan Branch2014-05-01
Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients (NCT01855880)AbGenomics B.V Taiwan Branch2013-05-01
Post Marketing Observational Study on Venezuelan Patients With Psoriasis (NCT01758705)AbbVie (prior sponsor, Abbott)2013-02-01
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE) (NCT01076192)AbbVie (prior sponsor, Abbott)2010-02-01
Community Based Trial for AMEVIVE® (NCT00168753)Astellas Pharma Inc2004-07-01

Track Moderate-to-severe Chronic Plaque Psoriasis automatically

Every clearance here is in the API, with alerts when new ones post.